These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33013889)

  • 41. Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.
    Chen DY; Chen YM; Chien HJ; Lin CC; Hsieh CW; Chen HH; Hung WT; Lai CC
    PLoS One; 2016; 11(12):e0168147. PubMed ID: 28005947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study.
    Liu X; Guo R; Meng X; Fang J; Lu L
    Front Immunol; 2020; 11():560744. PubMed ID: 33329521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity.
    Nirmala N; Brachat A; Feist E; Blank N; Specker C; Witt M; Zernicke J; Martini A; Junge G
    Pediatr Rheumatol Online J; 2015 Nov; 13():50. PubMed ID: 26589963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY; Wen MC
    Ann Rheum Dis; 2004 Oct; 63(10):1300-6. PubMed ID: 15361391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses.
    Jia J; Shi H; Liu M; Liu T; Gu J; Wan L; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Gong W; Yang C; Hu Q
    Front Immunol; 2019; 10():898. PubMed ID: 31068953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile.
    Ruscitti P; Barile A; Berardicurti O; Iafrate S; Di Benedetto P; Vitale A; Caso F; Costa L; Bruno F; Ursini F; Navarini L; Sensini F; Scarpa R; Frediani B; Cantarini L; Masciocchi C; Giacomelli R; Cipriani P
    Sci Rep; 2021 Jun; 11(1):12455. PubMed ID: 34127696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult‑onset Still's disease.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Gung NR; Hung WT; Tzang BS; Hsu TC
    Mol Med Rep; 2018 Feb; 17(2):3364-3371. PubMed ID: 29257322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease.
    Park JH; Kim HS; Lee JS; Kim JJ; Jung KH; Park YW; Yoo DH
    J Rheumatol; 2012 Oct; 39(10):2000-7. PubMed ID: 22859348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
    Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
    Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.
    Liao TL; Chen YM; Hsieh CW; Chen HH; Lee HC; Hung WT; Tang KT; Chen DY
    Sci Rep; 2017 Jun; 7(1):4214. PubMed ID: 28646209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
    Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease.
    Jung JY; Suh CH; Kim HA
    Expert Rev Mol Diagn; 2019 Jun; 19(6):459-468. PubMed ID: 31055973
    [No Abstract]   [Full Text] [Related]  

  • 57. Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.
    Segú-Vergés C; Coma M; Kessel C; Smeets S; Foell D; Aldea A
    Arthritis Res Ther; 2021 Apr; 23(1):126. PubMed ID: 33892792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.
    Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P
    Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
    Han JH; Ahn MH; Jung JY; Suh CH; Kwon JE; Yim H; Kim HA
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):67-73. PubMed ID: 31287410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.